James M. Shanahan
Oprichter bij SynDevRx, Inc.
Profiel
James M.
Shanahan was the founder of Jam Technologies, Inc. where he held the title of Vice President-Marketing from 1999 to 2009.
Mr. Shanahan is also the founder of SynDevRx, Inc.
Actieve functies van James M. Shanahan
| Bedrijven | Functie | Begin |
|---|---|---|
SynDevRx, Inc.
 SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Oprichter | - |
Eerdere bekende functies van James M. Shanahan
| Bedrijven | Functie | Einde |
|---|---|---|
Jam Technologies, Inc.
 Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Oprichter | 20-01-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Jam Technologies, Inc.
Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Electronic Technology |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
